Mead Johnson Nutrition Company
MJN
MJN was delisted on the 14th of June, 2017.
549 hedge funds and large institutions have $15B invested in Mead Johnson Nutrition Company in 2015 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 182 increasing their positions, 220 reducing their positions, and 66 closing their positions.
518% more call options, than puts
Call options by funds: $715M | Put options by funds: $116M
32% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 66
3% more funds holding
Funds holding: 532 → 549 (+17)
3% more capital invested
Capital invested by funds: $14.6B → $15B (+$374M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
17% less repeat investments, than reductions
Existing positions increased: 182 | Existing positions reduced: 220
Top Buyers
Top Sellers
MJN Hedge Fund Activity: Q4 2015 in Review
549 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Mead Johnson Nutrition Company (MJN) for Q4 2015, worth a combined $15B — up 2.6% from $14.6B a quarter earlier.
Buyers outnumbered sellers: 87 funds opened new MJN positions and 66 closed out — a net gain of 21 holders — while 182 added to existing stakes and 220 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $653M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $1.11B sold.
- 549 institutional investors held Mead Johnson Nutrition Company (MJN) as of Q4 2015, up from 532 in Q3 2015.
- Funds reported $15B of Mead Johnson Nutrition Company stock for Q4 2015, up 2.6% quarter-over-quarter.
- 87 funds opened new Mead Johnson Nutrition Company positions in Q4 2015 and 66 closed out, a net change of +21 holders.
- The largest Mead Johnson Nutrition Company buyer in Q4 2015 was Capital World Investors, an estimated $653M added.
- The largest Mead Johnson Nutrition Company seller in Q4 2015 was Americafirst Capital Management, an estimated $1.11B sold.
Based on aggregated 13F filings for Q4 2015.